Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

E162 - The PsychopharmaStahlogy Show: Management of Complex Treatment-Resistant Psychotic Disorders

E162 - The PsychopharmaStahlogy Show: Management of Complex Treatment-Resistant Psychotic Disorders

FromNEI Podcast


E162 - The PsychopharmaStahlogy Show: Management of Complex Treatment-Resistant Psychotic Disorders

FromNEI Podcast

ratings:
Length:
60 minutes
Released:
Oct 20, 2022
Format:
Podcast episode

Description

What made you both want to write the book “Management of Complex Treatment-Resistant Psychotic Disorders? What are some of the most challenging components to treat, when it comes to complex psychosis and how are these addressed in the book? In this episode, Dr. Andrew Cutler interviews Dr. Michael Cummings on how to manage complex treatment-resistant psychotic disorder. With this special series, brought to you by the NEI Podcast we will address a different theme in psychopharmacology every 3 months. Each theme is split into 3 parts, with one part released each month. This theme is on practical psychopharmacology. Episodes to be released under this theme include: Part 1: Management of Complex Treatment-Resistant Psychotic Disorders with Dr. Michael Cummings Part 2: Don’t Guess! Measure: The Clinical Use of Antipsychotic Plasma Levels with Dr. Jonathan Meyer Part 3: The Clozapine Handbook with Dr. Jonathan Meyer Subscribe to the NEI Podcast, so that you don’t miss another episode!
Released:
Oct 20, 2022
Format:
Podcast episode

Titles in the series (100)

The Neuroscience Education Institute (NEI) is committed to help raise the standard of mental health by providing imaginative medical education that focuses on the highest level of learning. Each episode offers an opportunity to learn about current issues in psychiatry from key opinion leaders in the medical field. NEI's Podcast would be of value to anyone with an interest in neuropsychiatric diseases and psychopharmacology.